Free Trial
OTCMKTS:REMI

Remedent (REMI) Stock Price, News & Analysis

Remedent logo
$0.0090 0.00 (0.00%)
As of 09/5/2025

About Remedent Stock (OTCMKTS:REMI)

Key Stats

Today's Range
$0.0090
$0.0090
50-Day Range
$0.0090
$0.01
52-Week Range
$0.01
$0.07
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive REMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Remedent and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

REMI Stock News Headlines

REMYY Rémy Cointreau SA
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.tc pixel
Peterson Remy
Remedent, Inc. (REMI)
See More Headlines

REMI Stock Analysis - Frequently Asked Questions

Remedent's stock was trading at $0.0550 at the start of the year. Since then, REMI shares have decreased by 83.7% and is now trading at $0.0090.

Shares of REMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Remedent investors own include AbbVie (ABBV), CoStar Group (CSGP), Enterprise Products Partners (EPD), Kellanova (K), Kandi Technologies Group (KNDI), MKS (MKSI) and M&T Bank (MTB).

Company Calendar

Today
9/08/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:REMI
CIK
1078037
Employees
4
Year Founded
1986

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$990 thousand
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
-0.13

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:REMI) was last updated on 9/8/2025 by MarketBeat.com Staff
From Our Partners